IL2 and neoplasm: This corroborates previous data on increased NK cell anti-tumor cytotoxicity following IL-2 administration51 and NK cell contribution to ICB response52 53 since they also express immunosuppressive IC molecules.54–56 As compared with the tumor growth delay experiments, in the depletion study the IgG-treated control group did not demonstrate tumor cure but significant growth delay.